More than six months after it launched a collaboration with Finland economic development agency FinPro, StartUp Health identified five health tech companies selected to join StartUp Health Finland. They will work out of a shared workspace at GE’s Health Innovation Village in Helsinki and will receive access to key US and global healthcare stakeholders and its global peer community.
Here’s a short description of the companies:
Brainshake, a s blood testing company that it intends to use its testing platform to identify chronic conditions. Teemu Suna is the CEO and co-founder.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
BuddyCare developed a surgery prep app as a patient engagement tool to help patients do what they need to do to prepare for a procedure. It’s also designed to keep them on track to recover from surgery. Jussi Määttä is the founder of the business.
GoodLife Technology, led by CEO Henrik Jürgens, developed the PT Momentum app to support physical therapy users. Currently, its app can only be used if users have received an exercise plan developed with PhysioTools Online.
HLD Health Life Devices is led by CEO Kalle Palomäki. The medical device company developed PhysioTouch to reduce swelling in trauma and surgery patients or patients who suffer from lymphedema.
LS CancerDiag led by Director and Partner Tuomas Poskiparta seeks to provide a reliable functional test to diagnose a common cancer-causing
condition, Lynch Syndrome, to enable preventive care.
In November, Eero Toivainen, a program director of Team Finland Health /Finpro said the program would give the country’s digital health entrepreneurs greater access to commercialization opportunities in the U.S. market through StartUp Health’s network. Although at the time he declined to get into details StartUp Health Finland’s funding, Toivainen said the Finnish government allocates about $100 million to investment in small- and medium-sized companies in the life sciences and digital health space.